Hongjin Xue

Hongjin Xue

Auto-generated profile, based on publicly available information

Hongjin Xue

Medical Engineering and Technology Research Center School of Radiology Shandong First Medical University & Shandong Academy of Medical Sciences Jinan 250117 P. R. China

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2018 in Journal of Materials Chemistry A
Verified
Journal Article
Closed access
PDF file
HXHongjin Xue
Hongjin Xue
ZNZhaolin Na
Zhaolin Na
YWYingqiang Wu
Yingqiang Wu
XWXuxu Wang
Xuxu Wang
QLQian Li
Qian Li
Jun MingJun Ming
Jun Ming
The uniqueness of the Co 3 O 4 /N-doped carbon nanospheres derived from a metal–organic framework offers new functional materials for lithium (ion) battery applications.

21 February 2025 in Small
Verified
Journal Article
Closed access
CLChaoran Liu
Chaoran Liu
XCXuetong Cao
Xuetong Cao
XMXinyu Ma
Xinyu Ma
YWYinchuan Wang
Yinchuan Wang
MZMeng Zhang
Meng Zhang
HXHongjin Xue
Hongjin Xue

1 May 2025 in Materials Today Bio
Verified
Journal Article
Open access
HXHongjin Xue
Hongjin Xue
YLYunqian Li
Yunqian Li
XMXinyu Ma
Xinyu Ma
QZQi Zhang
Qi Zhang
JZJunkai Zhu
Junkai Zhu
ZMZhen Mu
Zhen Mu
Psoriasis is a chronic skin condition with significant unmet medical needs, characterized by high levels of reactive oxygen species (ROS) and accompanying oxidative stress. In this study, we developed a novel single-atom iron nanozyme (Fe-N3), designed to mimic natural antioxidant enzymes, for the effective treatment of psoriasis. By optimizing the local coordination environment of Fe atoms, Fe-N3 demonstrated superior superoxide dismutase (SOD), catalase (CAT), ascorbate peroxidase (APx), and glutathione peroxidase (GPx)-like activities compared to Fe-N4. These properties enable efficient ROS scavenging and oxidative stress alleviation. Theoretical analyses revealed that Fe-N3 possesses lower energy barriers for ROS decomposition, explaining its superior catalytic performance. Furthermore, in vitro and in vivo experiments have demonstrated that Fe-N3 nanozyme exhibited remarkable therapeutic effects with extremely low cytotoxicity, effectively inhibiting pathological epidermal proliferation, downregulating key inflammatory factors, and reducing the expression levels of psoriasis-associated pathway proteins. This work highlights the promise of single-atom nanozymes in the curing of inflammatory skin diseases, advancing the transformative role of nanotechnology in biomedicine.